Navigation Links
AHIP Statement on Passage of Senate Finance Committee Legislation
Date:10/13/2009

WASHINGTON, Oct. 13 /PRNewswire-USNewswire/ -- America's Health Insurance Plans (AHIP) President and CEO Karen Ignagni released the following statement today on passage of health care reform legislation in the Senate Finance Committee:

"We strongly support comprehensive, bipartisan health care reform that covers all Americans, improves quality, and puts the health care system on an affordable, sustainable path. Health plans have proposed guaranteed coverage, elimination of pre-existing condition exclusions, and no longer basing premiums on health status or gender. Experience in the states has shown that market reforms need to paired with universal coverage to make health care as affordable as possible.

"While we agree with the objective of the current proposal, we are concerned about its workability and cost. The bill imposes hundreds of billions of dollars in new health care taxes and provides an incentive for people to wait until they are sick to purchase coverage. A recent analysis by PricewaterhouseCoopers found that these provisions will cause health care costs to increase far faster and higher than they would under the current system. We believe these issues can and should be addressed.

"Health plans will continue to work towards comprehensive, bipartisan health care reform that covers all Americans, improves quality, and makes coverage more affordable."

America's Health Insurance Plans - Providing Health Benefits to More Than 200 Million Americans

Key findings from a recent report by PricewaterhouseCoopers: http://www.americanhealthsolution.org/assets/Reform-Resources/AHIP-Reform-Resources/PWC-Report-on-Costs-Final.pdf

The analysis shows that the cost of the average family policy is approximately $12,300 today and will rise to:

'/>"/>
SOURCE America's Health Insurance Plans
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... March 01, 2015 Heart diseases are ... 10 percent of urban adult population and 5 percent ... heart diseases and 20-30 percent of them require specialized ... ailments and coronary vascular diseases (CVD). , A division ... new market research report titled “Indian Coronary Stent Market ...
(Date:2/28/2015)... The Classic Denture Center , located ... Throughout all of March patients can receive $25 ... service can help overall mouth health and give ... notice certain symptoms that suggest the denture teeth are ... , 1.    Pain, clicking, and popping in the joints, 2.    Pain ...
(Date:2/28/2015)... 28, 2015 A study out of ... gene therapy procedure for the treatment of a hereditary ... Authored by Dr. Robert MacLaren, professor of ... the Lancet Medical Journal on January 16, 2014 , ... rare genetic disorder that mostly affects men and leads ...
(Date:2/28/2015)... 28, 2015 Dr. Perry Patel ... area residents, recently announced a special offer for the ... treatment option for new and established patients at his Pismo ... a bright, white smile, Dr. Patel and his staff ... marked down from the regular price of $450. , ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an ... Scammers To Steal Your Data , which stresses the ease ... a DIY phishing kit, or any kind of malware kit ... important point about how everyone’s cyber security is intertwined when ... compromising legitimate content management systems or blogs in order to ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... may have discovered a better way to distinguish acute leukemia ... who need only standard therapy for cure., The study is ... Journal of Medicine with an accompanying editorial. , Researchers say ... cells to help control the kinds and amount of proteins ...
... April 30 Allscripts, the leading,provider of clinical ... improve healthcare, today announced results for the three,months ... ), Total revenue for the three months ... $65.0 million for the same period last year,increasing ...
... FOREST, Ill., April 30 Hospira, Inc.,(NYSE: HSP ... announced that Thomas E. Werner, senior vice president,Finance, and ... Bank of America 2008 Health Care Conference on Wednesday, ... Vegas., The presentation is scheduled to begin at ...
... determine which therapies will benefit certain patients , , ... understanding the extremely fine genetic underpinnings of acute ... which existing therapies will most benefit individual patients. ... physician pick a course of action" using existing ...
... Corporation announces,the launch of a new microsite featuring ... designed to complement Baxa direct sales efforts,and features ... use the site,s interactive tools to explore MedBoard ... frequently asked,questions and key product attributes., "The ...
... Average Prescription Savings of 14-45 ... ... ), one of the nation,s leading pharmacy benefit managers,announced its participation in ... Businesses and the health,care community have rallied around this program to raise ...
Cached Medicine News:Health News:Molecular change may reveal risk of leukemia relapse 2Health News:Molecular change may reveal risk of leukemia relapse 3Health News:Allscripts Reports First Quarter 2008 Results 2Health News:Allscripts Reports First Quarter 2008 Results 3Health News:Allscripts Reports First Quarter 2008 Results 4Health News:Allscripts Reports First Quarter 2008 Results 5Health News:Allscripts Reports First Quarter 2008 Results 6Health News:Allscripts Reports First Quarter 2008 Results 7Health News:Allscripts Reports First Quarter 2008 Results 8Health News:Allscripts Reports First Quarter 2008 Results 9Health News:Allscripts Reports First Quarter 2008 Results 10Health News:Genetic Changes May Dictate Course of Acute Myeloid Leukemia 2Health News:Genetic Changes May Dictate Course of Acute Myeloid Leukemia 3Health News:Baxa Launches Microsite Featuring the MedBoard(TM) Medication Tracking System 2Health News:Medco Joins Cincinnati's 'Cover the Uninsured Week' Effort To Deliver Lower Cost Health Care 2Health News:Medco Joins Cincinnati's 'Cover the Uninsured Week' Effort To Deliver Lower Cost Health Care 3
(Date:2/27/2015)... - La ... monitoraggio dell,infarto congestizio (CHF - Congestive Heart Failure) ...   Vectorious Medical Technologies, società ... il monitoraggio cardiaco destinato a pazienti affetti da ... concluso una raccolta di finanziamenti per 5 milioni ...
(Date:2/27/2015)... 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... pro forma net operating loss (NOL) guidance and its ... position.  Isis, significantly improved financial results were due in ... payments the Company received from its partners.  Isis, pro ... nearly 60% improvement over its 2013 NOL of $40.2 ...
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive campaign ... cut the rate of infection with a dangerous drug-resistant ... Clostridium difficile, or C.diff, is a bacterium ... inflammation of the colon. A recent article in the ... difficile Infection in the United States ...
Breaking Medicine Technology:Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3
... of aspirin in new super pill ORLANDO, Fla. ... (OTC Bulletin Board: CONX) announced today that its ... Indian POLYCAP Study (TIPS) to help determine patients, ... trial examined the effect of combinations of aspirin, ...
... QuatRx Pharmaceuticals, a privately-held biopharmaceutical company, today announced ... pivotal Phase 3 clinical trial of Ophena(TM) ... Phase 3 study of Ophena(TM) , the Company ... for Ophena(TM) , the most advanced estrogen-free oral ...
Cached Medicine Technology:Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09 2Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09 3QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3
The Medtronic ULTRAFLEX™ venous cannula provides you with excellent cannula flexibility. This new, unique design provides easy maneuvering during placement and kink resistant flexibility during ...
...
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures...
... Select CAP® cannulae provides a simple ... readings. An innovative combination of aortic ... line, the Select CAP® can provide ... arterial pressure readings on which you ...
Medicine Products: